Trevi Therapeutics, Inc. (TRVI)
13.17
-1.00
(-7.06%)
USD |
NASDAQ |
Dec 11, 16:00
13.21
+0.04
(+0.30%)
After-Hours: 05:13
Trevi Therapeutics EPS Diluted (Quarterly): -0.0813 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Arbutus Biopharma Corp. | -0.0404 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.80M |
| Total Expenses (Quarterly) | 11.80M |
| Enterprise Value | 1.495B |
| Earnings Yield | -2.82% |
| Normalized Earnings Yield | -2.819 |